Clinical trial
Immune Adverse Events Registry in Onco-Hematologic Patients Treated With Immunotherapy
NCT07198958 is registered in ClinicalTrials.gov with IRCCS San Raffaele as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Immune Adverse Events Registry in Onco-Hematologic Patients Treated With Immunotherapy
- Lead sponsor
- IRCCS San Raffaele
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- October 1, 2025
- Completion date
- September 30, 2045
- Enrollment
- 500 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
cancer, cancer (colon cancer, breast cancer, lymphoma, chronic lymphoma leukemia, multiple myeloma), cancer (solid tumors), cancer (with or without metastasis)